Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page:
About CDC.gov

Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Communication. ;
Centers for Disease Control and Prevention (U.S.), Office of Surveillance, Epidemiology and Laboratory Services., Public Health Informatics & Technology Program Office. ;
National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Cancer Prevention and Control. ;
...
More ▼

Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Communication. ;
Centers for Disease Control and Prevention (U.S.), Office of Surveillance, Epidemiology and Laboratory Services., Public Health Informatics & Technology Program Office. ;
National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Cancer Prevention and Control. ;
National Center for HIV, Viral Hepatitis, STD and TB Prevention (U.S.), Division of STD Prevention. ;
National Center for Immunization and Respiratory Diseases (U.S.), Division of Immunization Services. Less ▲

Reducing the burden of HPV-associated cancer and disease through vaccination in the US [streaming video] -- Public health importance of human papillomavirus infection and disease [PDF version of the PowerPoint presentation by Mona Saraiya, p. 1-17] -- Overview of HPV vaccines and impact monitoring [PDF version of the PowerPoint presentation by Eileen F. Dunne, p. 18-32] -- US HPV vaccination program : progress and challenges [PDF version of the PowerPoint presentation by Shannon Stokley, p. 33-50] -- What is needed to increase HPV vaccine coverage? [PDF version of the PowerPoint presentation by Amy B. Middleman, p. 51-69] -- Prevention of HPV-associated disease : global and domestic overview [PDF version of the PowerPoint presentation by Lauri Markowitz, p. 70-74].

This session of Grand Rounds explored the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. HPV is the most common sexually transmitted infection in the United States. There are more than 40 HPV types, some of which cause cancers and others which cause genital warts. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. Currently available HPV vaccines prevent infection from the HPV types that cause about 70% of cervical cancers and the majority of other HPV-attributable cancers. HPV vaccine has been recommended for routine vaccination of 11-12 year-old girls since 2006 and for 11-12 year-old boys since 2011. This session also provided more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.

Background : The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide update...

Objective : To provide background information for strengthening cervical cancer prevention in the Pacific by mapping current human papillomavirus (HPV) vaccination and cervical cancer screening practices, as well as intent and barriers to the introdu...

Neil Ferguson and colleagues estimate the disease burden of yellow fever in Africa, as well as the impact of mass vaccination campaigns. : Background : Yellow fever is a vector-borne disease affecting humans and non-human primates in tropical areas o...